Articles tagged "Liver grafts"

2018 American Transplant Congress
Post Reperfusion Portal Flow Rate Impacts Liver Allograft and Patient Survival in Patients with Pre Transplant Portal Vein Thrombosis
M. Rizzari, M. Safwan, M. Sobolic, S. Nagai, R. Schilke, K. Collins, A. Yoshida, M. Abouljoud.
Henry Ford Transplant Institute, Henry Ford Health System, Detroit, MI.
Background: Pre-transplant (pretx) portal vein thrombosis (PVT) not only makes the technical aspect of liver transplantation more challenging, it also is known to affect outcomes.…
2018 American Transplant Congress
Chronic Rejection: Risk Factors, Clinical Presentation and Outcome in Pediatric Liver Transplant Recipients: A Single Center Experience
T. Miloh, A. Cheng, D. Schady, R. Himes, K. Mysore, K. Hosek, J. Goss.
Texas Children's Hospital, Baylor College of Medicine, Houston, TX.
Chronic rejection (CR) is the leading indication for long term graft loss. We discuss our centers' experience with CR diagnosis and management. Method: Electronic medical…
2018 American Transplant Congress
Should More Donation after Cardiac Death Livers Be Used in Pediatric Transplantation?
C. Hwang,¹ S. Levea,² M. MacConmara.¹
¹Surgery, UT Southwestern Medical Center, Dallas, TX; ²Medicine, UT Southwestern Medical Center, Dallas, TX.
Introduction: Multiple strategies exist to increase the organ pool for livers in pediatric recipients, including using split livers, high risk livers, and donation after cardiac…
2018 American Transplant Congress
ABO‐incompatible Deceased Donor Liver Transplantation
X. Luo, C. Haugen, A. Thomas, J. Garonzik-Wang, D. Segev.
Johns Hopkins, Baltimore, MD.
ABO-incompatible liver transplantation (ILT) has increased over the past decade despite reports suggesting that adult ILT recipient have worse outcomes than ABO-compatible liver transplant (CLT)…
2018 American Transplant Congress
Liver Stiffness Measurement, but Not Controlled Attenuation Parameter, is Increased in Deceased Liver Donors at the Time of Transplant Procurement
A. Duarte-Rojo,¹ G. Barone,¹ D. Borja-Cacho,¹ W. Concepcion,² M. Shaheen,³ J. Heimbach,³ W. Kim.²
¹University of Arkansas for Medical Sciences, Little Rock, AR; ²Stanford University, Palo Alto, CA; ³Mayo Clinic, Rochester, MN.
Background & Aims: The growing obesity rate and IV drug use in the USA presage a higher usage of liver allografts with NAFLD or active…
2018 American Transplant Congress
Outcomes of Liver Transplant in Sequential Eras in Patients with Polycystic Liver Disease at Various Stages of Disease
C. Desai,¹ J. Shurney,¹ P. Serrano Rodriguez,¹ A. Barritt,¹ D. Gerber,¹ A. Gruessner.²
¹University of North Carolina, Chapel Hill, NC; ²SUNY Downstate Medical Center, Brooklyn, NY.
Patients with polycystic liver disease (PLD) receive liver transplants at various time points in their disease process. Some patients receive liver transplant alone (L), some…
2018 American Transplant Congress
Impact of Donor Hepatectomy Time during Organ Procurement in Donation after Circulatory Death Liver Transplantation; The United Kingdom Experience
S. Farid, A. Magdy, D. Vijayanand, V. Upasani, S. Willis, A. Barlow, H. Ernest, A. Niaz.
St James University Hospital, Leeds, United Kingdom.
IntroductionNo data exists to evaluate the impact of hepatectomy time (HT) during donation after cardiac death (DCD) procurement on short and long-term outcomes following liver…
2018 American Transplant Congress
Daptomycin Minimum Inhibitory Concentration (MIC) of Vancomycin Resistant Enterococcal (VRE) Blood Isolates Correlates with Allograft Failure in Orthotopic Liver Transplant (OLT) Recipients
R. Lee,¹ G. Haidar,² J. Lewis,³ S. Arif,⁴ J. Hand,⁵ E. Holaday,⁶ H. Clauss,⁶ J. Goldman,⁷ A. Nellore.¹
¹University of Alabama at Birmingham, Birmingham, AL; ²University of Pittsburgh Medical Center, Birmingham, AL; ³University of Virginia, Charlottesville, VA; ⁴Duke University, Durham, NC; ⁵Oschner Medical Center, New Orleans, LA; ⁶Department of Internal Medicine, Temple University, Philadelphia, PA; ⁷Temple University, Philadelphia, PA; ⁸Swedish Medical Center, Seattle, WA.
Background: Enterococci are one of the leading causes of nosocomial infection in after OLT. Unfortunately, treatment options for enterococci that are resistant to first-line agents…
2018 American Transplant Congress
LDLT for High MELD Recipients: A Single Center Experience
S. Ganesh, M. Molinari, T. Amit, H. Christopher, H. Abhinav.
Surgery, University of Pittsburgh, Pittsburgh, PA.
Objectives: Living donor liver transplantation (LDLT) is underutilized in high MELD patients. Our aim was to assess the impact of high MELD score on short-term…
2018 American Transplant Congress
Persistent Progressive Acute Kidney Injury and Graft Failure Post Liver Transplantation
T. Hussaini,^1,4 N. Partovi,^1,4 E. Yoshida,^2,4 S. Erb,^2,4 C. Scudammore,^3,4 S. Chung,^3,4 V. Marquez.^2,4
¹Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; ²Faculty of Medicine, Division of Gastroenterology, University of British Columbia, Vancouver, BC, Canada; ³Faculty of Medicine, Division of Surgery, University of British Columbia, Vancouver, BC, Canada; ⁴Liver Transplant Program, Vancouver General Hospital, Vancouver, BC, Canada.
Background:Acute kidney injury (AKI) in the setting of liver transplantation (LT) is a common and multifaceted complication. Recently, with the widespread adaptation of Acute Kidney…